Myt Netherlands [MYTE] vs RealReal [REAL] Detailed Stock Comparison
Myt Netherlands
NYSE
Loading...
RealReal
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Myt Netherlands wins in 8 metrics, RealReal wins in 10 metrics, with 0 ties. RealReal appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Myt Netherlands | RealReal | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -25.34 | -4.65 | Myt Netherlands |
| Price-to-Book Ratio | 1.61 | -1.92 | RealReal |
| Debt-to-Equity Ratio | 21.21 | -1.50 | RealReal |
| PEG Ratio | 27.29 | -22.15 | RealReal |
| EV/EBITDA | 66.44 | -55.96 | RealReal |
| Profit Margin (TTM) | -3.99% | -6.60% | Myt Netherlands |
| Operating Margin (TTM) | 3.19% | -7.98% | Myt Netherlands |
| EBITDA Margin (TTM) | 3.19% | N/A | N/A |
| Return on Equity | -8.21% | 32.94% | RealReal |
| Return on Assets (TTM) | 0.41% | -7.71% | Myt Netherlands |
| Free Cash Flow (TTM) | $-1.79M | $798,000 | RealReal |
| 1-Year Return | 118.62% | 198.53% | RealReal |
| Price-to-Sales Ratio (TTM) | 1.18 | 1.06 | RealReal |
| Enterprise Value | $844.97M | $1.02B | RealReal |
| EV/Revenue Ratio | 0.81 | 1.65 | Myt Netherlands |
| Gross Profit Margin (TTM) | 44.75% | 75.00% | RealReal |
| Revenue per Share (TTM) | $10 | $6 | Myt Netherlands |
| Earnings per Share (Diluted) | $-0.46 | $-1.08 | Myt Netherlands |
| Beta (Stock Volatility) | 1.09 | 2.46 | Myt Netherlands |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Myt Netherlands vs RealReal Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Myt Netherlands | 1.73% | 0.49% | 8.30% | -13.93% | -26.93% | 9.89% |
| RealReal | 3.05% | 4.10% | 37.39% | 52.92% | 2.01% | -17.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Myt Netherlands | 118.62% | -39.43% | -75.68% | -75.68% | -75.68% | -75.68% |
| RealReal | 198.53% | 257.71% | -50.37% | -71.90% | -71.90% | -71.90% |
Performance & Financial Health Analysis: Myt Netherlands vs RealReal
| Metric | MYTE | REAL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.04B | $651.43M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 140,280 | 2,746,770 |
| 90 Day Avg. Volume | 121,245 | 2,701,557 |
| Last Close | $8.22 | $8.12 |
| 52 Week Range | $3.22 - $12.50 | $2.24 - $11.38 |
| % from 52W High | -34.24% | -28.62% |
| All-Time High | $36.25 (Jan 18, 2021) | $30.22 (Feb 22, 2021) |
| % from All-Time High | -77.32% | -73.13% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.11% |
| Quarterly Earnings Growth | 0.04% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | -0.07% |
| Operating Margin (TTM) | 0.03% | -0.08% |
| Return on Equity (TTM) | -0.08% | 0.33% |
| Debt to Equity (MRQ) | 21.21 | -1.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.76 | $-2.97 |
| Cash per Share (MRQ) | $0.16 | $1.23 |
| Operating Cash Flow (TTM) | $-9,232,541 | $2.04M |
| Levered Free Cash Flow (TTM) | $30.78M | $-2,073,125 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Myt Netherlands vs RealReal
| Metric | MYTE | REAL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -25.34 | -4.65 |
| Forward P/E | 27.29 | -22.15 |
| PEG Ratio | 27.29 | -22.15 |
| Price to Sales (TTM) | 1.18 | 1.06 |
| Price to Book (MRQ) | 1.61 | -1.92 |
| Market Capitalization | ||
| Market Capitalization | $1.04B | $651.43M |
| Enterprise Value | $844.97M | $1.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.81 | 1.65 |
| Enterprise to EBITDA | 66.44 | -55.96 |
| Risk & Other Metrics | ||
| Beta | 1.09 | 2.46 |
| Book Value per Share (MRQ) | $4.76 | $-2.97 |
Financial Statements Comparison: Myt Netherlands vs RealReal
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MYTE | REAL |
|---|---|---|
| Revenue/Sales | $242.51M | $160.03M |
| Cost of Goods Sold | $133.98M | $40.01M |
| Gross Profit | $108.53M | $120.02M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-3.39M | $-12.77M |
| EBITDA | $-1.53M | $-2.41M |
| Pre-Tax Income | $-6.39M | $62.50M |
| Income Tax | $-898,000 | $95,000 |
| Net Income (Profit) | $-5.49M | $62.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MYTE | REAL |
|---|---|---|
| Cash & Equivalents | $14.24M | $139.60M |
| Total Current Assets | $445.93M | $208.15M |
| Total Current Liabilities | $240.53M | $239.99M |
| Long-Term Debt | $37.09M | $454.75M |
| Total Shareholders Equity | $415.95M | $-336.07M |
| Retained Earnings | $-146.47M | $-1.19B |
| Property, Plant & Equipment | $78.39M | $73.97M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MYTE | REAL |
|---|---|---|
| Operating Cash Flow | $31.74M | $59.53M |
| Capital Expenditures | N/A | $-4.71M |
| Free Cash Flow | $18.17M | $-35.85M |
| Debt Repayment | $-2.31M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MYTE | REAL |
|---|---|---|
| Shares Short | 630,461 | 20.20M |
| Short Ratio | 2.42 | 7.89 |
| Short % of Float | 0.04% | 0.18% |
| Average Daily Volume (10 Day) | 140,280 | 2,746,770 |
| Average Daily Volume (90 Day) | 121,245 | 2,701,557 |
| Shares Outstanding | 85.27M | 111.24M |
| Float Shares | 17.78M | 89.18M |
| % Held by Insiders | 0.86% | 0.12% |
| % Held by Institutions | 0.13% | 0.91% |
Dividend Analysis & Yield Comparison: Myt Netherlands vs RealReal
| Metric | MYTE | REAL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |